SCI Abstract

search
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma
Cell therapy using ex vivo reprogrammed macrophages enhances antitumor immune responses in melanoma
Macrophage-based cell therapies have shown modest success in clinical trials, which can be attributed to their phenotypic ...
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma
In vivo CAR T cell therapy against angioimmunoblastic T cell lymphoma
For angioimmunoblastic T cell lymphoma (AITL), a rare cancer, no specific treatments are available and survival outcome is...
Transcription factors in fibroblast plasticity and CAF heterogeneity
Transcription factors in fibroblast plasticity and CAF heterogeneity
In recent years, research focused on the multifaceted landscape and functions of cancer-associated fibroblasts (CAFs) aime...
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Targeting of RRM2 suppresses DNA damage response and activates apoptosis in atypical teratoid rhabdoid tumor
Atypical teratoid rhabdoid tumors (ATRT) is a rare but aggressive malignancy in the central nervous system, predominantly ...
CircGPRC5A enhances colorectal cancer progress by stabilizing PPP1CA and inducing YAP dephosphorylation
CircGPRC5A enhances colorectal cancer progress by stabilizing PPP1CA and inducing YAP dephosphorylation
With the advancements in bioinformatic technology, an increasing number of circular RNAs (circRNAs) have been discovered a...
Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling
Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling
Lung metastasis is the most adverse clinical factor and remains the leading cause of osteosarcoma-related death. Decipheri...
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer
Targeting PEG10 as a novel therapeutic approach to overcome CDK4/6 inhibitor resistance in breast cancer
Breast cancer is the global leading cancer burden in women and the hormone receptor-positive (HR+) subtype is a major part...